Private equity firms including Apollo Global Management (APO), Bain Capital, CVC Capital Partners, and Lone Star Funds are exploring potential offers for DSM-Firmenich's animal nutrition and health business, which could be valued at around 3 billion euros ($3.32 billion), Bloomberg reported late Wednesday, citing people familiar with the matter.
Dutch animal nutrition firm Nutreco and agricultural traders Archer-Daniels-Midland (ADM) and Cargill have also been invited to bid, the report said.
DSM-Firmenich, listed in Amsterdam with dual headquarters in the Netherlands and Switzerland, is working with UBS Group and Piper Sandler to gauge interest in the unit, the people told Bloomberg.
The company expects to receive indicative bids by April 17, Bloomberg said, adding discussions are ongoing and may not lead to a transaction.
Representatives for DSM-Firmenich, Apollo, Bain, CVC, Lone Star, UBS, and Piper Sandler didn't immediately respond to requests for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。